AMGEN INC is 105.2x more valuable than IOVANCE BIOTHERAPEUTICS, INC. by market capitalization ($191.70 B vs $1.82 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | IOVA | AMGN |
|---|---|---|
| Market cap | $1.82 B | $191.70 B |
| US-listed rank | #2181 | #79 |
| Revenue (latest FY) | $263.50M | $36.75B |
| Net income (latest FY) | -$391.00M | $7.71B |
| Net margin | -148.4% | 21.0% |
| P/E (trailing FY) | - | 24.9 |
| SEC filings | 1,005 | 1,011 |
AMGEN INC is 105.2x more valuable than IOVANCE BIOTHERAPEUTICS, INC. by market capitalization ($191.70 B vs $1.82 B).
In their latest fiscal years, IOVANCE BIOTHERAPEUTICS, INC. reported $263.50M in revenue while AMGEN INC reported $36.75B.
Full pages: IOVANCE BIOTHERAPEUTICS, INC. and AMGEN INC, or browse the full rankings.